1. Tao, Shanchun, Cui, Di, Cheng, Huimin, Chen, Hongwei, Gao, Yong. 2024. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma. In BMC cancer, 24, 194. doi:10.1186/s12885-024-11943-1. https://pubmed.ncbi.nlm.nih.gov/38347489/
2. Zhang, Huirong, Wong, Jason P, Ni, Guoxin, Dittmer, Dirk P, Damania, Blossom. 2022. Mitochondrial protein, TBRG4, modulates KSHV and EBV reactivation from latency. In PLoS pathogens, 18, e1010990. doi:10.1371/journal.ppat.1010990. https://pubmed.ncbi.nlm.nih.gov/36417478/
3. Guo, Haitao, Wang, Qi, Ghneim, Khader, Su, Lishan, Ting, Jenny P-Y. 2021. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication. In Nature immunology, 22, 423-433. doi:10.1038/s41590-021-00898-1. https://pubmed.ncbi.nlm.nih.gov/33767427/
4. Zeng, Xianke, Lee, Hye Kyung, Wang, Chaochen, Liu, Chengyu, Hennighausen, Lothar. 2020. The interdependence of mammary-specific super-enhancers and their native promoters facilitates gene activation during pregnancy. In Experimental & molecular medicine, 52, 682-690. doi:10.1038/s12276-020-0425-x. https://pubmed.ncbi.nlm.nih.gov/32321991/
5. Ramasubramanian, Abilasha, Ramani, Pratibha, Kannan, Balachander, Arumugam, Paramasivam. 2023. High expression of novel biomarker TBRG4 promotes the progression and invasion of oral squamous cell carcinoma. In Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 52, 738-745. doi:10.1111/jop.13470. https://pubmed.ncbi.nlm.nih.gov/37537882/
6. Wang, Ansheng, Zhao, Chengling, Liu, Xuegang, Chu, Shanshan, Gao, Yuan. 2017. Knockdown of TBRG4 affects tumorigenesis in human H1299 lung cancer cells by regulating DDIT3, CAV1 and RRM2. In Oncology letters, 15, 121-128. doi:10.3892/ol.2017.7328. https://pubmed.ncbi.nlm.nih.gov/29387213/